Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Maryland · 2026 Regular Session · Bill

SB 778: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 778 is a bill introduced in the Maryland Senate on February 6, 2026. According to its official title, it concerns: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership. Primary sponsor: Brian Feldman (Democratic). Most recent recorded action (April 28, 2026): Approved by the Governor - Chapter 206.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Brian FeldmanPrimary sponsorDemocraticSenate15

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Approved by the Governor - Chapter 206
  2. Returned Passed
  3. Third Reading Passed
  4. Favorable Adopted Second Reading Passed
  5. Favorable Report by Health
  6. Hearing 4/02 at 1:00 p.m.
  7. Referred Health
  8. Third Reading Passed
  9. Second Reading Passed with Amendments
  10. Favorable with Amendments {
  11. Favorable with Amendments Report by Finance
  12. Hearing 3/03 at 1:00 p.m.

Showing 12 most recent of 13 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source